XML 85 R60.htm IDEA: XBRL DOCUMENT v3.19.3
INTANGIBLE ASSETS AND GOODWILL - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Oct. 01, 2018
Jan. 01, 2018
Sep. 30, 2019
Sep. 30, 2018
Jun. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Mar. 31, 2018
Mar. 01, 2018
Dec. 31, 2017
Goodwill [Line Items]                      
Impairment of intangible assets           $ 38,000,000 $ 341,000,000        
Net carrying amount     $ 10,650,000,000     10,650,000,000   $ 12,001,000,000      
Decrease to net loss attributable to Bausch Health Companies Inc.     $ (49,000,000) $ (350,000,000)   $ (272,000,000) $ (3,804,000,000)        
Decrease to earnings per share, basic and diluted (in usd per share)     $ (0.14) $ (1.00)   $ (0.77) $ (10.83)        
Goodwill impairment     $ 0 $ 0   $ 0 $ 2,213,000,000        
Goodwill reallocated into (out of)     13,052,000,000     13,052,000,000   13,142,000,000     $ 15,593,000,000
Accumulated goodwill impairment charges     3,711,000,000     3,711,000,000          
Ortho Dermatologics                      
Goodwill [Line Items]                      
Goodwill impairment               2,213,000,000      
Dentistry Reporting Unit                      
Goodwill [Line Items]                      
Goodwill impairment $ 109,000,000             $ 109,000,000      
Reporting Units Excluding Dentistry                      
Goodwill [Line Items]                      
Goodwill impairment $ 0                    
Branded Rx | Adjustments                      
Goodwill [Line Items]                      
Goodwill reallocated into (out of)                   $ 115,000,000  
Branded Rx | Salix                      
Goodwill [Line Items]                      
Goodwill impairment   $ 1,970,000,000                  
Branded Rx | Ortho Dermatologics                      
Goodwill [Line Items]                      
Goodwill impairment   $ 243,000,000                  
Bausch Lomb/International and U.S. Diversified Products Segments | Adjustments                      
Goodwill [Line Items]                      
Goodwill reallocated into (out of)                 $ (115,000,000)    
Minimum                      
Goodwill [Line Items]                      
Reporting unit, impairment test, long-term growth rate 1.00%                    
Reporting unit, impairment test, estimated cash flows, discount rate 7.50%                    
Maximum                      
Goodwill [Line Items]                      
Reporting unit, impairment test, long-term growth rate 3.00%                    
Reporting unit, impairment test, estimated cash flows, discount rate 14.00%                    
Uceris                      
Goodwill [Line Items]                      
Impairment of intangible assets         $ 263,000,000            
Net carrying amount     70,000,000     70,000,000          
Xifaxan                      
Goodwill [Line Items]                      
Net carrying amount     $ 4,444,000,000     4,444,000,000          
Xifaxan | Intangible Assets, Amortization Period                      
Goodwill [Line Items]                      
Decrease to net loss attributable to Bausch Health Companies Inc.           $ 353,000,000          
Decrease to earnings per share, basic and diluted (in usd per share)           $ 1.00          
Acquired IPR&D not in service                      
Goodwill [Line Items]                      
Impairment of indefinite-lived intangible assets             28,000,000        
Held-for-sale                      
Goodwill [Line Items]                      
Impairment of long-lived assets classified as held for sale           $ 8,000,000 5,000,000        
Product/patent assets                      
Goodwill [Line Items]                      
Impairment of finite-lived intangible assets           $ 3,000,000 $ 60,000,000